Description
+ Include: 22 videos + 18 pdfs, size: 4.5 GB
+ Target Audience: physicians who care for oncology patients
+ Sample video: contact me for sample video
+ Information:
Tuesday, January 24, 2023, 7:50 AM – 5:00 PM, Online, New York , NY
Immunotherapeutics has changed the treatment modalities available to cancer patients in both solid tumors and hematologic malignancies. Since the breakthrough of ipilimumab, there have been fast-paced and ongoing advancements in the field of immunotherapy, revolutionizing clinical management rapidly.
This one-day live virtual course aims to improve cancer patient outcomes by advancing the science, development, and application of cancer immunology and immunotherapy through fundamental understanding and clinical application. Learners will review fundamental concepts and recent advances in immunotherapy designed to meet the learning needs of advanced practice providers (APPs) and other allied health professionals. Clinical application in solid tumor and hematologic malignancies will be discussed as well as toxicity management, including immune-related adverse events resulting from immune checkpoint inhibition. Experts will discuss the fundamentals of immune checkpoint blockade and CAR T cell therapy, as well as advancements in TIL and BITE therapy, novel combination therapy, and algorithmic management of immune-related adverse events. Toxicity management will be communicated through case study applications and demonstration of common, rare, and severe immune-related adverse events.
Who Should Attend
The target audience for this course includes nurse practitioners, physician assistants, certified registered nurse anesthetists, physicians, and nurses who care for oncology patients. We are pleased to offer complimentary registration for residents, fellows, APP students, and nursing students.
- Describe the principles surrounding the immunity cycle
- Explain fundamental principles of immunotherapeutic agents including immune checkpoint inhibition, CAR T CELL , TIL, and BITE therapies.
- Discuss clinical application of immune modulated agents in the oncology population
- Discuss the symptoms of Cytokine release Syndrome and clinical management
- Recognize and identify common, rare and severe immune related adverse events attributed to immune checkpoint inhibition
+ Topics:
Algorithmic Management and Grading of Immune-Related Adverse Events.mp4
Algorithmic Management and Grading of Immune-Related Adverse Events.pdf
APPImmunotherapy_2023_Brochure.pdf
BITE and CAR T cell therapy in the Acute Leukemia Patient- A Case Study Approach.mp4
BITE and CAR T cell therapy in the Acute Leukemia Patient- A Case Study Approach.pdf
Cardiac Immune-Related Adverse Event- Myocarditis.mp4
Cardiac Immune-Related Adverse Event- Myocarditis.pdf
Clinical Application of Immune Checkpoint Inhibitors in Solid Tumor Malignancy Panel Discussion.mp4
Clinical Application of Immune Therapy in Hematologic Malignancy Panel Discussion.mp4
Clinical Considerations for Immune Checkpoint Toxicities Panel Discussion.mp4
Clinical Updates in Head and Neck Squamous Cell Carcinoma.mp4
Clinical Updates in Head and Neck Squamous Cell Carcinoma.pdf
Clinical Updates in Lymphoma.mp4
Clinical Updates in Lymphoma.pdf
Clinical Updates in Metastatic Breast Cancer.mp4
Clinical Updates in Metastatic Breast Cancer.pdf
Clinical Updates in Myeloma.mp4
Clinical Updates in Myeloma.pdf
Clinical Updates in Rectal Squamous Cell Carcinoma.mp4
Clinical Updates in Rectal Squamous Cell Carcinoma.pdf
Clinical Updates in Sarcoma and Merkel Cell Carcinoma.mp4
Clinical Updates in Sarcoma and Merkel Cell Carcinoma.pdf
Clnical Updates in Non-Small Cell Lung Cancer.mp4
Clnical Updates in Non-Small Cell Lung Cancer.pdf
Cytokine Release Syndrome.mp4
Cytokine Release Syndrome.pdf
Discussion of Novel Checkpoint Inhibitors and Combination Therapy.mp4
Discussion of Novel Checkpoint Inhibitors and Combination Therapy.pdf
Fundamentals of Immune Checkpoint Blockade Panel Discussion.mp4
Fundamentals of T Cell Therapy Panel Discussion.mp4
Gastrointestinal Immune-Related Adverse Event- Colitis.mp4
Gastrointestinal Immune-Related Adverse Event- Colitis.pdf
Mechanism of Action and Clinical Applications of Tumor Infiltrating Lymphocytic (TIL) Therapy.mp4
Mechanism of Action and Clinical Applications of Tumor Infiltrating Lymphocytic (TIL) Therapy.pdf
Mechanism of Action of Checkpoint Blockade PD1, PDL1, CTLA-4.mp4
Mechanism of Action of Checkpoint Blockade PD1, PDL1, CTLA-4.pdf
Neurological Immune-Related Adverse Event- Myasthenia Gravis.mp4
Neurological Immune-Related Adverse Event- Myasthenia Gravis.pdf
Overview of Chimeric Antigen Receptor (CAR) T Cell Immunotherapy.mp4
Overview of Chimeric Antigen Receptor (CAR) T Cell Immunotherapy.pdf
Reviews
There are no reviews yet.